GSK plc (GSK) stock
GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$48.58−0.66 (-1.34%)
Close on Nov 18, 2026Market cap $104.82BP/E 13.2Yield –
GSK price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
GSK's price to book ratio was 4.8× on Nov 11, 2026, against 5.5× a year earlier. Over the last 5 years it ranged from 3.6× to 6.0×, with a median of 5.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.8× | −0.8 |
| 2025 | Dec 31, 2025 | 5.5× | +1.4 |
| 2024 | Dec 31, 2024 | 4.2× | −1.4 |
| 2023 | Dec 29, 2023 | 5.6× | +1.7 |
| 2022 | Dec 30, 2022 | 3.9× | −1.6 |
| 2021 | Dec 31, 2021 | 5.5× | −0.3 |
| 2020 | Dec 31, 2020 | 5.8× | −17.0 |
| 2019 | Dec 31, 2019 | 22.8× | −33.8 |
| 2018 | Jan 31, 2018 | 56.6× | +0.5 |
| 2017 | Dec 29, 2017 | 56.2× | – |
See a number that looks wrong?